GENE | Genetic Technologies Limited

Index- P/E- EPS (ttm)-0.37 Insider Own- Shs Outstand15.39M Perf Week-3.85%
Market Cap18.80M Forward P/E- EPS next Y- Insider Trans- Shs Float13.09M Perf Month0.82%
Income-5.70M PEG- EPS next Q- Inst Own1.00% Short Float / Ratio0.62% / 0.50 Perf Quarter-26.78%
Sales5.80M P/S3.24 EPS this Y7.20% Inst Trans-23.89% Short Interest0.08M Perf Half Y-14.24%
Book/sh0.47 P/B2.03 EPS next Y- ROA-42.50% Target Price- Perf Year-24.75%
Cash/sh0.17 P/C5.70 EPS next 5Y- ROE-50.90% 52W Range0.83 - 2.40 Perf YTD2.35%
Dividend- P/FCF- EPS past 5Y27.90% ROI-43.80% 52W High-60.34% Beta1.60
Dividend %- Quick Ratio2.00 Sales past 5Y67.30% Gross Margin55.40% 52W Low14.69% ATR0.06
Employees52 Current Ratio2.10 Sales Q/Q44.10% Oper. Margin- RSI (14)40.95 Volatility3.99% 6.35%
OptionableYes Debt/Eq0.06 EPS Q/Q-40.50% Profit Margin-97.90% Rel Volume0.26 Prev Close0.96
ShortableYes LT Debt/Eq0.03 Earnings- Payout- Avg Volume160.22K Price0.95
Recom- SMA20-1.86% SMA50-8.54% SMA200-18.80% Volume41,126 Change-0.81%
May-26-23 03:00PM
May-23-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-19-23 08:00AM
08:00AM Loading…
Mar-27-23 08:00AM
Mar-13-23 08:00AM
Feb-09-23 08:00AM
Feb-07-23 10:00AM
Feb-06-23 08:00AM
Feb-03-23 08:35AM
Feb-01-23 02:22PM
08:00AM Loading…
Jan-30-23 08:00AM
Jan-24-23 08:00AM
Jan-11-23 08:00AM
Dec-06-22 08:00AM
Nov-10-22 08:00AM
Nov-09-22 08:00AM
Oct-25-22 09:14AM
Oct-13-22 08:00AM
Sep-29-22 08:00AM
Sep-02-22 08:00AM
Aug-30-22 08:00AM
Jul-28-22 08:00AM
Jul-18-22 08:00AM
Jul-14-22 08:00AM
Jul-05-22 08:00AM
08:00AM Loading…
Jul-01-22 08:00AM
Jun-16-22 08:00AM
May-16-22 09:00AM
Apr-08-22 08:00AM
Feb-23-22 08:00AM
Feb-22-22 08:00AM
Jan-19-22 09:00AM
Dec-21-21 08:00AM
Dec-10-21 07:30AM
Dec-09-21 07:30AM
Oct-25-21 08:30AM
Oct-04-21 08:00AM
Sep-30-21 09:00AM
Sep-28-21 08:04AM
Sep-09-21 09:00AM
Aug-31-21 09:00AM
Aug-16-21 08:00AM
Jul-26-21 08:25AM
Jul-19-21 09:27AM
Jul-09-21 08:00AM
Jun-11-21 08:00AM
Jun-01-21 08:00AM
May-13-21 09:01AM
Apr-26-21 08:00AM
Apr-12-21 09:37AM
Apr-09-21 11:15AM
Mar-04-21 07:00AM
Feb-26-21 09:20AM
Jan-25-21 04:00PM
Jan-21-21 11:30AM
Dec-02-20 09:00AM
Dec-01-20 09:50AM
Nov-23-20 04:30PM
Nov-17-20 08:30AM
Oct-01-20 08:00AM
Sep-15-20 08:00AM
Sep-11-20 08:33AM
Sep-01-20 04:45PM
Jul-20-20 08:30PM
Jul-16-20 08:02AM
Jul-15-20 08:00AM
Jun-23-20 08:00AM
Jun-18-20 08:00AM
Jun-04-20 04:49PM
May-28-20 09:00PM
May-26-20 09:22AM
May-22-20 04:05PM
May-20-20 09:15AM
Apr-23-20 08:00AM
Apr-20-20 08:00AM
Apr-17-20 08:00AM
Apr-06-20 06:00AM
Apr-01-20 12:45PM
Mar-13-20 08:15PM
Mar-12-20 07:35PM
Jan-13-20 09:00AM
Jan-07-20 11:45AM
Jan-06-20 11:24PM
Dec-17-19 09:00AM
Dec-10-19 07:00AM
Nov-15-19 08:30AM
Nov-05-19 07:00AM
May-22-19 03:11PM
May-17-19 01:30PM
May-10-19 08:10AM
May-03-19 08:45AM
Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.